{"id":5670,"date":"2017-08-02T20:09:56","date_gmt":"2017-08-03T00:09:56","guid":{"rendered":"http:\/\/localhost:10028\/practiceareas\/byetta\/"},"modified":"2022-06-21T16:54:06","modified_gmt":"2022-06-21T20:54:06","slug":"byetta","status":"publish","type":"practiceareas","link":"https:\/\/napolilaw.lemonadestand.org\/de\/praxisbereiche-2\/byetta\/","title":{"rendered":"Byetta Attorneys"},"content":{"rendered":"<p>Die US Food &amp; Drug Administration (FDA) hat Byetta (Wirkstoff Exenatid) im Jahr 2005 f\u00fcr die Behandlung von Typ-II-Diabetes zugelassen. Durch Injektion verabreicht, haben Millionen von Menschen Byetta eingenommen, um den Blutzuckerspiegel zu senken. Trotz seiner Bundeszulassung hat sich Byetta als ein Medikament erwiesen, das sowohl fehlerhaft als auch gef\u00e4hrlich ist. Ein Anwalt kann Ihnen dabei helfen, einen Schadensersatzanspruch geltend zu machen, wenn Sie Byetta eingenommen und dadurch einen Schaden erlitten haben.<\/p>\n<p>&nbsp;<\/p>\n<h3>Byetta im Zusammenhang mit Bauchspeicheldr\u00fcsenkrebs und Schilddr\u00fcsenkrebs<\/h3>\n<p>Napoli Shkolnik, PLLC is currently investigating cases for patients who have been diagnosed pancreatic cancer and thyroid cancer\u00a0while taking or after taking Byetta. These are potentially life-threatening conditions that may have a tremendous impact on a patient and his or her family, and we are prepared to seek financial compensation that can cover medical bills, lost income and the other losses and injuries associate with these side effects. Contact our offices today, or continue reading to learn more about this type 2 diabetes medication and the side effects it may cause.<\/p>\n<p>One of the most recent developments in Byetta side effects involves pancreatic cancer. According to a new study by researchers at the University of California, Los Angeles (UCLA), evidence of pre-cancerous cellular changes were found in diabetic patients taking incretin mimetics. The Food and Drug Administration (FDA) released a Drug Safety Communication regarding this new study in March of 2013, stating that the agency would evaluate the findings of this study. Incretin mimetics are a class of diabetic drugs, including Byetta, Januvia, Victoza and several others.<\/p>\n<p>&nbsp;<\/p>\n<h3>\u00dcber Byetta<\/h3>\n<p>Since it was approved by the U.S. Food and Drug Administration in 2005, millions of prescriptions for Byetta (exenatide) have been dispensed across the nation. From 2005 through 2009 alone, 7 million Byetta prescriptions were dispensed. Byetta is an injectable prescription medication for the treatment of type 2 diabetes, injected twice daily within 60 minutes before the first and last meals of the day. It stimulates the production of insulin in the pancreas and causes the stomach to empty itself more slowly. Combined with diet and exercise and possibly other diabetes medications, Byetta is meant to bring blood sugar to a more optimum level.<\/p>\n<p>Byetta is not a cure for type 2 diabetes, a condition that has been diagnosed in millions of Americans. It is instead meant to control this type of diabetes by stimulating insulin production. It is estimated that many more Americans are at risk of developing type 2 diabetes or are unaware that they are in the early stages of the condition.<\/p>\n<p>With the number of patients currently suffering from type 2 diabetes, it is no wonder that so many Byetta prescriptions have been written and filled. Unfortunately, as the drug increased in popularity it became evident that patients were suffering from serious side effects.<\/p>\n<p>&nbsp;<\/p>\n<h3>Gef\u00e4hrliche Nebenwirkungen von Byetta<\/h3>\n<p>Byetta wurde mit einer Reihe schwerwiegender Gesundheitsprobleme in Verbindung gebracht, von denen einige t\u00f6dlich sein k\u00f6nnen, wenn sie nicht behandelt werden. Diese beinhalten:<\/p>\n<ul>\n<li>Nierenprobleme, einschlie\u00dflich Nierenversagen; Und<\/li>\n<li>Entz\u00fcndung der Bauchspeicheldr\u00fcse (Pankreatitis), die so schwer ist, dass sie zum Tod f\u00fchrt.<\/li>\n<\/ul>\n<p>Tats\u00e4chlich erhielt die FDA zwischen den Jahren 2005 und 2008 <a href=\"http:\/\/www.fda.gov\/Drugs\/DrugSafety\/PostmarketDrugSafetyInformationforPatientsandProviders\/DrugSafetyInformationforHeathcareProfessionals\/ucm188656.htm\" target=\"_blank\" rel=\"noopener noreferrer\">78 Berichte von Patienten, die Nierenprobleme entwickelt hatten<\/a> als direkte Folge der Einnahme von Byetta. 18 von ihnen ben\u00f6tigten eine Dialyse, zwei eine Nierentransplantation und vier starben.<\/p>\n<p>&nbsp;<\/p>\n<h3>Habe ich einen Klagegrund gegen den Hersteller von Byetta?<\/h3>\n<p>Wenn Sie glauben, dass Sie als direkte Folge der Einnahme von Byetta gesch\u00e4digt wurden, k\u00f6nnen Sie gegen den Hersteller von Byetta \u2013 Amylin Pharmaceuticals \u2013 oder eine andere Partei entlang der Herstellungs- oder Vertriebskette klagen. Um Schadensersatz in einer Zivilklage geltend zu machen, m\u00fcssen Sie die Fahrl\u00e4ssigkeit des Herstellers des Medikaments beweisen und dass Ihnen das fehlerhafte Medikament einen Schaden zugef\u00fcgt hat. Beispiele f\u00fcr Fahrl\u00e4ssigkeit k\u00f6nnen sein:<\/p>\n<ul>\n<li>Vers\u00e4umnis, Byetta vor der Ver\u00f6ffentlichung angemessen zu testen;<\/li>\n<li>Vers\u00e4umnis, Daten offenzulegen, die das Risiko von Byetta veranschaulichen;<\/li>\n<li>Unterlassene Bekanntgabe von Risiken (Warnung); oder und<\/li>\n<li>Herstellung und Vertrieb eines gef\u00e4hrlichen Medikaments trotz bekannter Risiken.<\/li>\n<\/ul>\n<p>Sie m\u00fcssen auch nachweisen, dass Ihr Schaden ohne die Einnahme von Byetta nicht entstanden w\u00e4re.<\/p>\n<p>&nbsp;<\/p>\n<h3>Ergreifen Sie jetzt rechtliche Schritte, um Sch\u00e4den geltend zu machen<\/h3>\n<p>Although Byetta is still approved for the treatment of type 2 diabetes in adults, it is possible that patients may experience serious and life-changing side effects. Some may even be at risk of losing their lives from these. Those who have suffered injury of this kind may be entitled to financial compensation for pain, suffering, medical care and lost earnings. Future medical expenses and loss of future earnings may also be covered, depending on the case.<\/p>\n<p>Since 2000 alone, the attorneys at Napoli Shkolnik, PLLC have recovered in excess of $2 billion in settlements and awards. We are fully committed to representing the interests of the injured, helping them seek justice in the wake of the physical pain, emotional trauma and financial losses they have experienced. We go up against the most formidable opponents, negotiating fair settlements and fighting for favorable verdicts in order to help our clients begin rebuilding and moving on with their lives. We are ready to see how we can help with your Byetta lawsuit and welcome you to <a href=\"\/de\/kontaktiere-uns\/\">Kontakt<\/a> a <a href=\"\/de\/praxisbereiche-2\/pharma-rechtsstreitigkeiten\/\">Anwalt f\u00fcr Pharmazeutika<\/a> at our law office to discuss your rights and options. Your initial consultation is free.<\/p>\n<p>Depending upon the state in which you live, the statute of limitations for filing a defective drug claim is usually between two and four years from the date of discovery of illness. To ensure that you file a claim within the time limits, make sure you contact the attorneys at Napoli Shkolnik, PLLC as soon as possible. We are ready to meet with you today!<\/p>","protected":false},"excerpt":{"rendered":"<p>The U.S. Food &amp; Drug Administration (FDA) approved Byetta (active ingredient exenatide) for the treatment of type II diabetes in 2005. Given via injection, millions of individuals have taken Byetta&#8230;<\/p>","protected":false},"featured_media":0,"menu_order":59,"template":"","practiceareas_category":[743],"class_list":["post-5670","practiceareas","type-practiceareas","status-publish","hentry","practiceareas_category-pharmaceutical-litigation"],"acf":[],"_links":{"self":[{"href":"https:\/\/napolilaw.lemonadestand.org\/de\/wp-json\/wp\/v2\/practiceareas\/5670","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/napolilaw.lemonadestand.org\/de\/wp-json\/wp\/v2\/practiceareas"}],"about":[{"href":"https:\/\/napolilaw.lemonadestand.org\/de\/wp-json\/wp\/v2\/types\/practiceareas"}],"version-history":[{"count":0,"href":"https:\/\/napolilaw.lemonadestand.org\/de\/wp-json\/wp\/v2\/practiceareas\/5670\/revisions"}],"wp:attachment":[{"href":"https:\/\/napolilaw.lemonadestand.org\/de\/wp-json\/wp\/v2\/media?parent=5670"}],"wp:term":[{"taxonomy":"practiceareas_category","embeddable":true,"href":"https:\/\/napolilaw.lemonadestand.org\/de\/wp-json\/wp\/v2\/practiceareas_category?post=5670"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}